Latest Posts

Trials in treating STIs, vaccines and lipid lowering medications

By Bench Side Story — 3 days ago

Since joining Paratus Clinical Research in 2022, Dr Pi Lip Seet has served as both Principal Investigator and Sub-Investigator across Phase I–IV industry-sponsored clinical trials. His research experience spans vaccines, immunology, cardiovascular and endocrine disease, respiratory medicine, gastroenterology, pain management, sleep medicine and adult psychiatry. He has been involved in multiple vaccine development programs, including RSV, influenza, COVID-19, herpes zoster and pneumococcal studies.

Post Views: 107

Therapy to prevent hepatocellular carcinoma in people with liver cirrhosis

By Bench Side Story — 2 weeks ago

Professor John Olynyk is a Gastroenterologist & Hepatologist with over 30 years’ experience, primarily at The Fiona Stanley & Fremantle Hospital Group. He planned the Gastroenterology and Hepatology Service for the Fiona Stanley Hospital and was Head Department from 2010 until 2020.

Professor John Olynyk was appointed as Associate Dean and Head of the Medical Discipline at Curtin University in 2023 until 2025 and is now Associate Director, Clinical Engagement, Curtin Medical Research Institute, Curtin University.

Identification & characterisation of molecular drivers of therapeutic resistance

By Bench Side Story — 2 weeks ago

Professor Pieter Eichhorn is an internationally experienced cancer biologist and research leader whose career has been defined by high-impact contributions at the interface of functional genomics, translational oncology, and research infrastructure strategy.

He completed his PhD at the University of Newcastle upon Tyne, contributing to the cloning of the gene associated with Cornelia de Lange Syndrome, before undertaking postdoctoral training at the Netherlands Cancer Institute in the laboratory of René Bernards. There, he performed pioneering functional genetic screens that identified key regulators of oncogenesis and therapy resistance, including critical roles for the PI3K signalling pathway in resistance to targeted breast cancer therapies.

Liver cancer & patient-derived tumour organoids

By Bench Side Story — 2 weeks ago

Dr Benjamin Dwyer is a translational cancer researcher driven by a clear purpose: to ensure discoveries made in the laboratory genuinely improve outcomes for patients.

Based at Curtin University, he established and now leads the organoid platform within the Liver Cancer Collaborative and directs the WA Organoid Innovation Hub, working at the intersection of biology, medicine and biotechnology to accelerate new treatments for liver cancer.

Developing upper limb motor biomarkers of dementia

By Bench Side Story — 2 weeks ago

Kaylee is currently a research fellow with the Wicking Dementia Research and Education Centre at the University of Tasmania. She has recently submitted her PhD thesis, reporting the findings of her research on developing upper limb motor biomarkers of dementia. She has postgrad degrees in physiotherapy and experience working in the community and aged care across Tasmania for several years, where she worked with people with dementia.

Metabolic phenotyping, lipidomics & bioinformatics in dementia

By Bench Side Story — 2 weeks ago

Dr Luke Whiley is a dementia researcher whose work focuses on understanding how the body’s metabolism, particularly the biology of fats known as lipids, influences our health throughout ageing.

His research explores how the body responds to illness, lifestyle, and environmental stress at a chemical level, and how these responses shape longterm disease risk. Using advanced blood-based measurement technologies, Dr Whiley studies thousands of small molecules at once to build a snapshot of a person’s metabolic health. By combining these measurements with data science approaches, his work identifies biological pathways that become disrupted in disease, providing insight into why some people are more vulnerable to conditions such as dementia.

Cellular mechanisms of traumatic brain injury & concussion

By Bench Side Story — 3 weeks ago

Professor Melinda Fitzgerald is Deputy Vice Chancellor, Research at Curtin University, John Curtin Distinguished Professor and CEO of Connectivity Traumatic Brain Injury Australia.

She has published over 135 papers; recent highlights include Lancet Neurology, J Neuroscience, Nature Nano, ACS Nano, Biomaterials. Currently held grants/Projects total $10.1 million; CIA for $5.2 million of these; $18.5 million total research and equipment funding, $9.9 million as CIA; continuous category 1 grant funding as CIA since 2009.

Leukaemia microenvironment & high risk childhood leukaemia

By Bench Side Story — 3 weeks ago

Associate Professor Laurence Cheung is now an Associate Professor at the Curtin Medical School as well as Curtin Medical Research Institute, and a Co-head of the Leukaemia Translational Research Laboratory at The Kids.

He has attracted over $8.7 million in research funding, including 16 awards as CIA (over $6.1 million). Assoc Prof Cheung was named the 2019 Cancer Council of WA Early Career Cancer Researcher of the Year and received the STEM Early Career Research Award at Curtin University in 2019.

Post Views: 109

Novel therapy for pancreatic cancers, targeting molecular foundation

By Bench Side Story — 3 weeks ago

Dr Michael Lee is an experienced medical oncologist, sub-specialising in gastrointestinal cancers and neuroendocrine tumours at the Peter MacCallum Cancer Centre.

He plays a key role in molecular tumour boards at VCCC Alliance (Victorian Comprehensive Cancer Centre) and MPCCC (Monash Partners Comprehensive Cancer Consortium), ensuring the accurate and effective use of precision medicine in cancer care across the state.

Post Views: 108

Genetics and Environmental Factors of Glaucoma & Myopia

By Bench Side Story — 3 weeks ago

Professor David Mackey’s original research, over more than 30 years into the genetics of glaucoma and in the fields of optic atrophy and congenital cataract, has received constant professional accolades, attracted ongoing research funding and led to his publication of more than 400 peer-reviewed papers.

1
2
3
…
17
Next ›

Scroll to top